Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

January 22, 2013

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

March 07, 2012

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.